Synthesis and characterization of stable fluorocarbon nanostructures as drug delivery vehicles for cytolytic peptides - Wikidata - awgldk - TriplyDB

Synthesis and characterization of stable fluorocarbon nanostructures as drug delivery vehicles for cytolytic peptides

Synthesis and characterization of stable fluorocarbon nanostructures as drug delivery vehicles for cytolytic peptides

http://www.wikidata.org/entity/Q37260780

about

Molecular imaging of atherosclerosis with nanoparticle-based fluorinated MRI contrast agents Delivery of a Protease-Activated Cytolytic Peptide Prodrug by Perfluorocarbon Nanoparticles.Recent Advances in (19)Fluorine Magnetic Resonance Imaging with Perfluorocarbon Emulsions.Perfluorocarbon nanoparticles: evolution of a multimodality and multifunctional imaging agent.Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer.Simulation of fusion-mediated nanoemulsion interactions with model lipid bilayers.Targeted Nanocarriers for Imaging and Therapy of Vascular Inflammation.Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions Comparison of surfactants used to prepare aqueous perfluoropentane emulsions for pharmaceutical applications Polymeric micelles in anticancer therapy: targeting, imaging and triggered release.Nanomedicine strategies for molecular targets with MRI and optical imaging.Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics.Rapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac function Mechanisms of nucleotide trafficking during siRNA delivery to endothelial cells using perfluorocarbon nanoemulsions.Perfluorocarbon nanoemulsions with fluorescent, colloidal and magnetic properties Identification of a novel lytic peptide for the treatment of solid tumours.Lipid membrane editing with peptide cargo linkers in cells and synthetic nanostructures.Targeting of alpha(nu)beta(3)-integrins expressed on tumor tissue and neovasculature using fluorescent small molecules and nanoparticles Characterization of perfluorooctylbromide-based nanoemulsion particles using atomistic molecular dynamics simulations NIR-labeled perfluoropolyether nanoemulsions for drug delivery and imaging.Post-formulation peptide drug loading of nanostructures for metered control of NF-κB signaling Synthesis and characterization of perfluoro-tert-butyl semifluorinated amphiphilic polymers and their potential application in hydrophobic drug delivery Cell Labeling for 19F MRI: New and Improved Approach to Perfluorocarbon Nanoemulsion Design.Nanoparticle incorporation of melittin reduces sperm and vaginal epithelium cytotoxicity.Pharmacokinetics of quercetin-loaded nanodroplets with ultrasound activation and their use for bioimaging Measuring melittin uptake into hydrogel nanoparticles with near-infrared single nanoparticle surface plasmon resonance microscopy Small Molecule MYC Inhibitor Conjugated to Integrin-Targeted Nanoparticles Extends Survival in a Mouse Model of Disseminated Multiple Myeloma.Interaction of melittin peptides with perfluorocarbon nanoemulsion particles.Programmable nanoparticle functionalization for in vivo targeting.Dual-therapy with αvβ3-targeted Sn2 lipase-labile fumagillin-prodrug nanoparticles and zoledronic acid in the Vx2 rabbit tumor model.Postformulation peptide drug loading of nanostructures.Minute dosages of alpha(nu)beta3-targeted fumagillin nanoparticles impair Vx-2 tumor angiogenesis and development in rabbits Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth.Suppression of NF-κB activity via nanoparticle-based siRNA delivery alters early cartilage responses to injury.Amphiphilic hyperbranched fluoropolymers as nanoscopic 19F magnetic resonance imaging agent assemblies Anti-angiogenic Nanotherapy Inhibits Airway Remodeling and Hyper-responsiveness of Dust Mite Triggered Asthma in the Brown Norway Rat.Grading the commercial optical biosensor literature-Class of 2008: 'The Mighty Binders'.Cytolytic peptide nanoparticles ('NanoBees') for cancer therapy.The fluorous effect in biomolecular applications.Peptide delivery using phospholipid micelles.

P2860

Q27027613-BE797D90-1FA6-4965-89CC-FA218486392B Q27301457-A2AB047A-B025-40F5-8829-BF87B770CDEA Q30385272-A2317DEE-407E-46DF-B87E-0B43BD5CE8C8 Q30434964-B6F48B79-BA3D-4A81-B191-895545035A13 Q30450131-8264F2BA-857E-4183-B798-37816BC9FCFA Q30459662-924EEE96-AA9C-4625-ACD6-C2EA1ABBC87D Q30466992-6E608791-94EE-4629-BAE2-6CA1EA7166EB Q30474759-37A68075-FD6F-40B9-913C-1C276EEF2EBB Q30475933-CAF0386D-DA89-45B7-AD11-B0739FF804FC Q30478123-0133B6A9-7C00-4CFF-8017-70D4D4E6687C Q30481471-F890DD88-88BF-4DD7-8C5D-EC0FCD468CF3 Q30486235-6C8936CE-8A01-4262-91B1-C878F4AD7E33 Q30576097-05A5256B-8777-4790-B252-6A231B3DCEE7 Q33684461-372C2EC7-32B2-4AE4-9A47-F8FDDF6D9C05 Q33760320-02AA2034-49BE-4823-8C47-7C98B787DC6A Q33925341-AF84CF3B-5878-4DB7-BE52-73C85D325A79 Q34017152-BF1FEE2C-8AAD-4EC5-A421-06DBA9EA3D04 Q34037800-3DC5FCCC-0478-4903-A24C-3CDB1A1D5B0E Q34051542-F837A757-BD8E-4785-BD53-A4046947B305 Q34295364-04EE47A6-CCD2-4635-9611-15DEA096A3B1 Q34381627-05AFF7F0-FB7F-4A1A-9661-348D8DED95CA Q34441150-06F12E7C-3B94-4B90-868E-1540AC1FD1A0 Q34680859-67B957DD-7440-4AA0-B2DE-F025A5654160 Q35153213-7E50406F-49D0-4230-8F49-A8E92B2DF58D Q35532147-D6C17DD2-663A-42A2-B241-D6C32491C95F Q35580290-5C869353-6D52-404D-AE72-E0E2702E1D0A Q35590573-6771D078-E76B-4B87-98A8-3F67767A73DB Q35631698-2E5E1B92-0D07-4064-9037-6775293B1F63 Q36482886-00334FFF-ED0C-4CD2-BD37-8F19B49F6DF4 Q36505441-00CFD732-CE5D-4990-96CB-1B4C996ADC81 Q36780035-1EA4D516-55E1-4206-A574-A5C461083846 Q36804990-8F146060-25B0-4B33-BDC3-643733E7681A Q37328406-7C817924-C01C-4D60-8090-4AF2BA8D63FF Q37346907-F3648C95-A5B6-4E23-B242-BA0CAE506739 Q37349125-A229F037-AB9C-46A4-A00C-15489F6D9217 Q37541992-2A27033B-8D9B-4856-AEBE-8DA861F4B41E Q37657355-14B9F3B4-0F20-4C77-92CC-4E6C7ADF218B Q37827768-04EAB337-B9DF-4767-8FB6-0B87C7A89AAA Q37892383-5C9EE39F-8A01-4CCB-8978-BE0FF9CE32BD Q38030889-1B3AD3D9-491B-41A9-8FBC-0874AB7842DF

P2860

Synthesis and characterization of stable fluorocarbon nanostructures as drug delivery vehicles for cytolytic peptides

http://www.wikidata.org/entity/Q37260780

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 February 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Synthesis and characterization ...... ehicles for cytolytic peptides

@en

Synthesis and characterization ...... hicles for cytolytic peptides.

@nl

type

label

Synthesis and characterization ...... ehicles for cytolytic peptides

@en

Synthesis and characterization ...... hicles for cytolytic peptides.

@nl

prefLabel

Synthesis and characterization ...... ehicles for cytolytic peptides

@en

Synthesis and characterization ...... hicles for cytolytic peptides.

@nl

P1433

Q37260780-9649B26E-BB99-4782-8BE3-E7E11E42DE94

P1476

Q37260780-845E0EEE-0FAC-4239-9B2A-530D1C7A7CBF

P2093

Q37260780-29640C61-7894-488C-AEC3-4533236DC981

Q37260780-52B7D45F-BC61-415B-B94F-C307AAB3EB63

Q37260780-6BCF222E-D04D-42CE-8DB7-520B1A68EFBE

Q37260780-AEF314CB-BCE6-46AE-A3CA-9BB0D7FA1962

Q37260780-FBCA0C48-D703-4C0C-B9FB-448C1315722B

P2860

Q37260780-3489816E-E175-42D6-A41C-95125E7069EE

Q37260780-53BB6500-29C9-457B-9AE9-B2B445B59B14

Q37260780-5C93EF3C-985A-40FE-B4BA-464C5531CCA6

Q37260780-5DCFB3E8-2CD0-403E-A4FB-87A31300DAA9

Q37260780-65271046-1546-4225-9FBC-5601FB7ED0F9

Q37260780-6D3F463C-8D3D-416C-B98A-0BF778EC9C5A

Q37260780-704604F7-0302-4993-A740-12EF3DB6E759

Q37260780-72D02F9B-E916-4531-8CB9-F0F364F3C571

Q37260780-7AD29D62-509D-4867-AE2E-D5568289B909

Q37260780-87643AF0-05D5-4E6A-B40F-51AD20B381FB

P304

Q37260780-F09C9EEE-26E5-4F62-9032-ED6863FDA5FC

P31

Q37260780-7D011074-E846-4506-9977-5769F7579FE6

P356

Q37260780-492BDA14-E773-4F2A-B021-817F730EF649

P407

Q37260780-4F2189DB-5386-4A3B-B111-AA0F49DF918D

P433

Q37260780-B706312E-4E19-4CD1-B03B-8A80E20B1484

P478

Q37260780-A142E577-BEA1-4186-A98B-44A39CF3E7F5

P577

Q37260780-5ADDA620-E9C7-4343-AA64-2DE0974C54E8

P5875

Q37260780-B606D4C0-58C4-4BA2-B28D-A37245EB72C8

P698

Q37260780-316D9FAC-CA5F-4CF1-AE88-BCC6C272D2B2

P921

Q37260780-D4875B6F-0632-45F1-B331-88AE886981C7

P932

Q37260780-7AE63129-1F21-4BC4-9F72-11F5F3EF708B

P356

P1433

P1476

Synthesis and characterization ...... ehicles for cytolytic peptides

@en

P2093

Gregory M Lanza

http://www.w3.org/2001/XMLSchema#string

John M Heuser

http://www.w3.org/2001/XMLSchema#string

Neelesh R Soman

http://www.w3.org/2001/XMLSchema#string

Paul H Schlesinger

http://www.w3.org/2001/XMLSchema#string

Samuel A Wickline

http://www.w3.org/2001/XMLSchema#string

P2860

Studies on anticancer activities of antimicrobial peptides

Barrel-stave model or toroidal model? A case study on melittin pores.

BAX-dependent transport of cytochrome c reconstituted in pure liposomes.

Anchor chain length alters the apparent mechanism of chloride channel function in SCMTR derivatives.

Dynamic structure of vesicle-bound melittin in a variety of lipid chain lengths by solid-state NMR.

The sting. Melittin forms channels in lipid bilayers.

Oxygen carriers ("blood substitutes")--raison d'etre, chemistry, and some physiology.

Reversible merger of membranes at the early stage of influenza hemagglutinin-mediated fusion

Novel paramagnetic contrast agents for molecular imaging and targeted drug delivery.

Deep-etch EM reveals that the early poxvirus envelope is a single membrane bilayer stabilized by a geodetic "honeycomb" surface coat.

P304

1131-1136

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/NL073290R

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2008-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5550779

http://www.w3.org/2001/XMLSchema#string

P698

18302330

http://www.w3.org/2001/XMLSchema#string

P921

P932

2710241

http://www.w3.org/2001/XMLSchema#string